Nancy Ying Ying Lee | Academic Influence

Why Is Nancy Ying Ying Lee Influential?

Nancy Ying Ying Lee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (2004) (2682)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) (2120)
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. (2015) (1442)
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. (2001) (964)
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. (2012) (711)
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. (2003) (640)
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. (2009) (576)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. (2016) (483)
The abscopal effect associated with a systemic anti-melanoma immune response. (2013) (361)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) (2019) (327)
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. (2006) (299)
Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. (2003) (286)
Postoperative complications of salvage total laryngectomy (2005) (284)
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. (2012) (269)
Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer (2008) (247)
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. (2008) (235)
Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. (2002) (230)
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. (2008) (226)
Salvage re-irradiation for recurrent head and neck cancer. (2007) (226)
Intensity‐modulated radiation therapy in head and neck cancers: An update (2007) (211)
Basal cell and squamous cell skin cancers. (2010) (207)
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. (2007) (207)
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform (2017) (179)
Long‐term regional control and survival in patients with “low‐risk,” early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation (2013) (178)
PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma (2009) (177)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. (2017) (175)
The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. (2008) (174)
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. (2006) (163)
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy (2019) (162)
18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma (2012) (160)
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. (2012) (158)
Decision making in the management of recurrent head and neck cancer (2014) (154)
Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. (2008) (146)
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. (2020) (143)
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020) (143)
Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. (2016) (142)
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. (2006) (139)
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. (2011) (138)
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. (2007) (136)
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. (2021) (136)
Intensity‐modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma (2008) (132)
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma (2013) (132)
Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. (2008) (131)
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. (2012) (130)
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques (2017) (129)
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. (2009) (123)
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. (2017) (121)
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. (2011) (121)
Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes. (2016) (120)
Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? (2007) (120)
Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. (2009) (118)
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. (2008) (116)
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. (2016) (115)
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. (2014) (115)
Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. (2014) (115)
Intensity-modulated radiation therapy for head and neck carcinoma. (2007) (114)
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. (2009) (112)
Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States. (2016) (111)
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors (2021) (106)
Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland (2009) (105)
Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? (2007) (104)
A multi‐institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity‐modulated radiotherapy (2015) (104)
Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. (2000) (104)
Proton therapy for head and neck cancer: expanding the therapeutic window. (2017) (99)
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. (2010) (99)
Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. (2000) (98)
Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. (2010) (96)
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline. (2021) (96)
Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. (2003) (92)
Oral cavity and oropharynx tumors. (2007) (90)
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. (2012) (90)
Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. (2003) (89)
Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. (2006) (88)
Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer (2010) (88)
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. (2017) (87)
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. (2008) (86)
Effects of exercise on swallowing and tongue strength in patients with oral and oropharyngeal cancer treated with primary radiotherapy with or without chemotherapy. (2014) (86)
Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer (2015) (85)
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. (2011) (82)
Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. (2009) (79)
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. (2011) (78)
Intensity-Modulated Radiation Therapy in Head and Neck Cancers: Dosimetric Advantages and Update of Clinical Results (2005) (78)
Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. (2008) (77)
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. (2005) (77)
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. (2017) (76)
Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? (2011) (73)
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging (2008) (73)
Nasopharyngeal carcinoma. (2015) (73)
Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience (2014) (72)
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy. (2010) (71)
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. (2006) (71)
International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. (2019) (70)
A phase 2 study of bevacizumab with cisplatin plus intensity‐modulated radiation therapy for stage III/IVB head and neck squamous cell cancer (2012) (70)
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. (2008) (67)
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. (2012) (67)
A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. (2014) (65)
Long Term Regional Control and Survival in Patients with “Low Risk” Early Stage Oral Tongue Cancer Managed by Partial Glossectomy and Neck Dissection without Postoperative Radiation: The Importance of Depth of Invasion (2011) (64)
Radiotherapy After Surgical Resection for Head and Neck Mucosal Melanoma (2009) (63)
Proton Therapy for Head and Neck Cancers. (2018) (63)
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck (2016) (62)
Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations (2015) (62)
Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review (2012) (62)
Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. (2010) (60)
Head-and-neck target delineation among radiation oncology residents after a teaching intervention: a prospective, blinded pilot study. (2009) (59)
High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results. (2007) (59)
Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy. (2019) (58)
Adenoid Cystic Carcinoma of the Major Salivary Glands Treated with Surgery and Radiation (2005) (58)
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. (2015) (58)
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. (2021) (57)
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement (2020) (57)
External‐beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society (2016) (57)
The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. (2009) (57)
A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC). (2018) (56)
Management of primary skin cancer during a pandemic: Multidisciplinary recommendations (2020) (56)
Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia. (2018) (56)
Advances in nasopharyngeal carcinoma (2005) (55)
An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer (2010) (55)
Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer. (2007) (54)
Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent (2016) (54)
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response (2016) (54)
Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity‐modulated radiotherapy with concurrent chemotherapy (2012) (54)
Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. (2017) (54)
Technology for Innovation in Radiation Oncology. (2015) (53)
The role of external beam radiotherapy in the treatment of papillary thyroid cancer. (2006) (53)
Long‐term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation (2017) (50)
Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma. (2015) (50)
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. (2013) (50)
Postoperative intensity‐modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity (2008) (50)
Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy. (2019) (49)
Patterns of recurrence in oral tongue cancer with perineural invasion (2018) (49)
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC). (2014) (49)
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non‐anaplastic non‐medullary thyroid cancer (2014) (49)
Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. (2013) (48)
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features. (2017) (47)
Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases (2009) (47)
Radiation Impairs Perineural Invasion by Modulating the Nerve Microenvironment (2012) (47)
Patterns of regional and distant metastasis in esthesioneuroblastoma (2016) (47)
Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients. (1999) (46)
Current and emerging treatment options for nasopharyngeal carcinoma (2012) (46)
Treatment‐related toxicities in older adults with head and neck cancer: A population‐based analysis (2015) (46)
Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature (2012) (45)
Human papillomavirus 16 promotes microhomology-mediated end-joining (2019) (45)
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics (2013) (45)
Proton Therapy for Head and Neck Cancer (2018) (44)
Intravoxel incoherent motion diffusion‐weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma (2016) (44)
Dosimetric distribution to the tooth-bearing regions of the mandible following intensity-modulated radiation therapy for base of tongue cancer. (2012) (44)
Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. (2016) (44)
910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) (2020) (42)
A population-based atlas and clinical target volume for the head-and-neck lymph nodes. (2004) (42)
Comparing Primary Tumors and Metastatic Nodes in Head and Neck Cancer Using Intravoxel Incoherent Motion Imaging: A Preliminary Experience (2013) (42)
New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. (2008) (42)
Migration from full‐head mask to “open‐face” mask for immobilization of patients with head and neck cancer (2013) (42)
Evaluation of Different Methods of 18F-FDG-PET Target Volume Delineation in the Radiotherapy of Head and Neck Cancer (2008) (41)
Patient Reflections on Decision Making for Laryngeal Cancer Treatment (2017) (40)
Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (2015) (40)
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy (2014) (40)
Predictors of outcome for advanced‐stage supraglottic laryngeal cancer (2009) (39)
A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. (2011) (39)
Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years (2018) (37)
Tumor Immunity and Immunotherapy for HPV-Related Cancers. (2021) (37)
Intensity modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience (2004) (37)
Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull (2003) (36)
Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose. (2005) (36)
Treatment outcomes for patients with synovial sarcoma of the head and neck (2008) (36)
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity‐modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma (2016) (36)
Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer. (2016) (36)
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control (2014) (36)
Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer (2013) (35)
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer (2017) (35)
Phase II Study of Concurrent and Adjuvant Chemotherapy with Intensity Modulated Radiation Therapy (IMRT) or Three-dimensional Conformal Radiotherapy (3D-CRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer (NPC)[RTOG 0615]: Preliminary Toxicity Report (2010) (34)
Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer (2016) (33)
JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer. (2019) (33)
Erratum: American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer (Thyroid (2012) 22:11 (1104-1139)) (2012) (32)
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan. (2014) (32)
Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response. (2016) (32)
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM (2016) (32)
Phase II Multi-institutional Study of Intensity Modulated Radiation Therapy (IMRT) +/− Chemotherapy for Nasopharyngeal (NPC) Carcinoma: Preliminary Clinical Results of RTOG 0225 (2008) (32)
High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. (2010) (32)
Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer (2017) (31)
Facility Volume and Survival in Nasopharyngeal Carcinoma. (2018) (31)
Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: a single institutional experience (2003) (31)
External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors (2013) (31)
Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome (2011) (31)
Clinical Utility of 18 F-FDG PET / CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer (2008) (31)
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab (2016) (31)
A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer. (2004) (31)
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer (2020) (30)
Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma (2018) (30)
The distance discordance metric—a novel approach to quantifying spatial uncertainties in intra- and inter-patient deformable image registration (2014) (30)
Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab (2009) (29)
High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. (2012) (28)
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. (2020) (27)
A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma. (2020) (27)
The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement. (2019) (27)
Using an onboard kilovoltage imager to measure setup deviation in intensity‐modulated radiation therapy for head‐and‐neck patients (2007) (27)
Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience. (2002) (26)
Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy (2009) (26)
Concurrent chemotherapy and radiotherapy for head and neck cancer (2009) (26)
Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients (2009) (26)
Comparison of Intensity-Modulated Radiotherapy Using Helical Tomotherapy and Segmental Multileaf Collimator-based Techniques for Nasopharyngeal Carcinoma: Dosimetric Analysis Incorporating Quality Assurance Guidelines from RTOG 0225 (2010) (26)
A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. (2004) (26)
Why target the globe?: 4-year report (2009-2013) of the Association of Residents in Radiation Oncology Global Health Initiative. (2014) (25)
Results of photon radiotherapy for unresectable salivary gland tumors: is neutron radiotherapy’s local control superior? (2014) (25)
Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience. (2015) (25)
Intensity‐modulated radiation therapy (2008) (25)
Sparing Bilateral Neck Level IB in Oropharyngeal Carcinoma and Xerostomia Outcomes (2015) (24)
Radiation therapy in the management of Merkel cell carcinoma: current perspectives. (2011) (24)
Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma (2011) (24)
The role of radiation therapy in the treatment of medullary thyroid cancer. (2010) (24)
Microcystic adnexal carcinoma of the face treated with radiation therapy: A case report and review of the literature (2012) (24)
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. (2012) (23)
Impact of elective neck dissection on the outcome of oral squamous cell carcinomas arising in the maxillary alveolus and hard palate (2016) (23)
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. (2018) (23)
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab. (2020) (23)
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer (2020) (23)
Accurate positioning for head and neck cancer patients using 2D and 3D image guidance (2010) (23)
Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. (2017) (23)
Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus. (2018) (22)
Radiation therapy for cutaneous melanoma. (2012) (22)
Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer. (2012) (22)
Salvage surgery for recurrent larynx cancer (2019) (22)
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies (2020) (22)
The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer (2020) (22)
Erratum: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An uptade of the UCSF experience (International Journal of Radiation Oncology Biology Physics (2002) 53 (12-22)) (2002) (21)
Intensity‐modulated radiotherapy for head and neck surgeons (2016) (21)
International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma. (2021) (21)
Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue. (2003) (21)
Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy (2019) (21)
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). (2014) (21)
Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center. (2019) (20)
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer (2016) (20)
PSIGAN: Joint Probabilistic Segmentation and Image Distribution Matching for Unpaired Cross-Modality Adaptation-Based MRI Segmentation (2020) (20)
Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base (2017) (20)
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy (2021) (20)
Radiographic osteoradionecrosis of the jaw with intact mucosa: Proposal of clinical guidelines for early identification of this condition. (2015) (20)
Radiation Therapy in the Treatment of Minor Salivary Gland Tumors (2014) (20)
Long-term Neck Control Rates After Complete Response to Chemoradiation in Patients With Advanced Head and Neck Cancer (2007) (20)
Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer. (2014) (20)
Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT). (2016) (20)
Hypopharyngeal squamous cell carcinoma: Three‐dimensional or Intensity‐modulated radiotherapy? A single institution's experience (2016) (19)
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. (2022) (19)
Merkel cell carcinoma. Clinical practice guidelines in oncology. (2004) (19)
Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. (2013) (19)
JAVELIN head and neck 100: A phase 3 trial of avelumab in combination with chemoradiotherapy (CRT) vs CRT for 1st-line treatment of locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). (2017) (19)
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease. (2018) (19)
Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy (2022) (18)
Treatment Deescalation Strategies for Nasopharyngeal Cancer: A Review. (2020) (18)
Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma (2017) (18)
Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature (2019) (18)
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. (2019) (17)
Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy. (2017) (17)
Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results. (2009) (17)
Long‐term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery (2018) (17)
Adjuvant radiation in the TORS era: Is there a benefit to omitting the tumor bed? (2017) (17)
The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity‐modulated radiotherapy era (2017) (17)
Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation (2015) (17)
Should cetuximab replace Cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer? (2013) (17)
A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09 (2001) (17)
Marginal recurrences after selective targeting with intensity‐modulated radiotherapy for oral tongue cancer (2012) (17)
Target Volume Delineation and Field Setup (2013) (17)
Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy (2014) (17)
Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma (2015) (17)
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study. (2016) (17)
Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma (2011) (16)
Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma (2016) (16)
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base (2020) (16)
Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times (2016) (16)
A Magnetic Resonance Imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer. (2017) (15)
The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. (2017) (15)
Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review (2016) (15)
18 F-FDG PET / CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma (2012) (15)
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. (2020) (15)
Past, present and future of proton therapy for head and neck cancer. (2020) (15)
KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma. (2019) (14)
Non-invasive imaging prediction of tumor hypoxia: a novel developed and externally validated CT and FDG-PET-based radiomic signatures. (2020) (14)
Repeatability of Quantitative Diffusion-Weighted Imaging Metrics in Phantoms, Head-and-Neck and Thyroid Cancers: Preliminary Findings (2019) (14)
Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma (2017) (14)
Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor. (2016) (14)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma (2018) (14)
Association of Number of Dissected Lymph Nodes With Survival in Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma Patients Undergoing Primary Surgery: A Population-Based Analysis (2017) (13)
Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer (2013) (13)
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis (2022) (12)
Impact of concomitant chemoradiation on survival for patients with T1‐2N1 head and neck cancer (2017) (12)
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach (2019) (12)
Merkel cell carcinoma: Clinical practice guidelines in oncology™ (2006) (11)
Intra-fraction patient motion in head/neck cancer patients undergoing intensity-modulated radiation therapy (IMRT) (2003) (11)
Phase II study of chemoradiation plus bevacizumab (BV) for locally/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615. (2011) (11)
The head and neck cancer genome in the era of immunotherapy. (2020) (11)
Computational Modeling of Interstitial Fluid Pressure and Velocity in Head and Neck Cancer Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Feasibility Analysis (2020) (11)
Offline Quality Assurance for Intensity Modulated Radiation Therapy Treatment Plans for NRG-HN001 Head and Neck Clinical Trial Using Knowledge-Based Planning (2020) (10)
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies. (2020) (10)
Simplifying intensity‐modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma (2007) (10)
Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial (2002) (10)
Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer (2019) (10)
Phase II Multi-Institutional Study of IMRT ± Chemotherapy for Nasopharyngeal Carcinoma (RTOG 0225): Preliminary Results (2007) (10)
High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck. (2016) (10)
Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer (2020) (10)
A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma. (2007) (10)
Basal cell and squamous cell skin cancers. Clinical practice guidelines in oncology. (2004) (9)
Prognostic significance of human papillomavirus and Epstein‐Bar virus in nasopharyngeal carcinoma (2019) (9)
Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot (2018) (9)
Target Volume Delineation and Treatment Planning for Particle Therapy (2018) (9)
Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients. (2017) (9)
Irradiation for locoregionally recurrent, never‐irradiated oral cavity cancers (2015) (9)
The effect of significant tumor reduction on the dose distribution in intensity modulated radiation therapy for head-and-neck cancer: a case study. (2009) (9)
The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model (2020) (9)
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence (2021) (8)
Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC). (2019) (8)
Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma (2011) (8)
Case study of the integration of electronic patient‐reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities (2020) (8)
Accurate positioning for head and neck cancer patients using 2D and 3D image guidance (2010) (8)
Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC). (2019) (8)
Dermatofibrosarcoma protuberans. (2022) (8)
Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation. (2017) (8)
Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks (2018) (8)
Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy? (2021) (7)
Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer (2016) (7)
Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14). (2019) (7)
Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT. (2016) (7)
Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy‐free survival in those refusing surgery (2019) (7)
A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC). (2017) (7)
Self-derived organ attention for unpaired CT-MRI deep domain adaptation based MRI segmentation (2020) (7)
Secondary skull base malignancies in survivors of retinoblastoma: the memorial sloan kettering cancer center experience. (2011) (7)
Prospectively-validated deep learning model for segmenting swallowing and chewing structures in CT (2021) (7)
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers. (2020) (7)
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer (2021) (7)
Investigation of a Novel Decision Support Metric for Head and Neck Adaptive Radiation Therapy Using a Real-Time In Vivo Portal Dosimetry System (2019) (6)
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy (2021) (6)
The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer. (2021) (6)
Fistula Formation After Postoperative Radiation Treatment for Paranasal Sinus Cancer (2008) (6)
Percutaneous Endoscopic Gastrostomy (PEG) in Oropharyngeal Cancer (OPC) Patients Treated with Intensity Modulated Radiotherapy (IMRT) (2011) (6)
Rationale, Instrumental Accuracy, and Challenges of PET Quantification for Tumor Segmentation in Radiation Treatment Planning (2012) (6)
Proton beam radiation therapy treatment for head and neck cancer (2021) (6)
Long‐term quality of life in older patients with HPV‐related oropharyngeal cancer (2018) (6)
A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer (2021) (6)
A method to account for dose fractionation by using a modified equivalent uniform dose algorithm (2003) (6)
Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma (2012) (6)
Cisplatin (CDDP) and Radiation (RT) versus Cetuximab (C) and RT in the Context of Human Papillomavirus (HPV) and P16 in the Treatment of Locally Advanced Head and Neck Cancer (LAHNC) (2010) (6)
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot (2021) (6)
The Importance of Locoregional Therapy in Metastatic Nasopharyngeal Cancer. (2020) (6)
Radiation Therapy and Management of the Cervical Lymph Nodes and Malignant Skull Base Tumors (2010) (6)
Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution. (2018) (5)
Counterpoint: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers. (2005) (5)
Intensity-modulated radiation therapy in the treatment of head and neck cancer involving the base of the skull. (2007) (5)
Use of Human Papillomavirus 16 (HPV16) Cell Free DNA for Assessment of Response to Chemoradiation in HPV-Associated Oropharyngeal Cancer (2015) (5)
The contemporary management of cancers of the sinonasal tract in adults (2022) (5)
Feasibility of reirradiation of recurrent sinonasal carcinoma in the periorbital region using hypofractionated image‐guided intensity‐modulated radiation therapy (2011) (5)
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). (2014) (5)
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer. (2022) (4)
Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft‐Tissue Sarcoma in a National Cohort (2020) (4)
Optimal Treatment Selection of Stereotactic Body Radiation Therapy and Intensity Modulated Radiation Therapy for Reirradiation of Head and Neck Cancer: A Multi-Institution Comparison (2016) (4)
Intensity-modulated radiation therapy for head and neck cancer (2004) (4)
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer (2022) (4)
Correlation of planned dose to area postrema and dorsal vagal complex with clinical symptoms of nausea and vomiting in oropharyngeal cancer (OPC) patients treated with radiation alone using IMRT (2013) (4)
Patterns of failure after salvage re-irradiation for recurrent head and neck cancer: implications for field design and consolidation therapy (2014) (4)
Intensity‐modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial (2021) (4)
Can Radiotherapy Quality Assurance (RT QA) improve nasopharyngeal cancer outcomes in low- and middle-income countries (LMICs) - Reporting the first phase of a prospective International Atomic Energy Agency (IAEA) study. (2021) (4)
Comparison of three treatment techniques involving IMRT fields for head and neck cancers (2002) (4)
Predicting radiation dosimetric distribution in different regions of the jaw in patients receiving radiotherapy for squamous cell carcinoma of the tonsil (2019) (4)
Hypofractionated Dose-painting Intensity Modulated Radiation Therapy (DP-IMRT) with Chemotherapy in the Treatment of Nasopharyngeal Carcinoma (NPC), a Prospective Trial (2009) (4)
Long-term survival in oligometastatic head and neck cancer patients. (2017) (4)
Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?: Definitive Management of Head-and-Neck Squamous Cell Carcinoma (2014) (4)
Measurement of IMRT Head and Neck Setup Error Using an On-board Kilovoltage Imager (2005) (4)
Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment. (2021) (4)
Risk Stratification Based on HPV and Smoking Status Independently Predicts Outcome in Patients With Oropharyngeal Cancer Treated With Surgery and Postoperative Radiation (2014) (4)
Intensity-modulated radiation therapy (IMRT) for advanced oropharyngeal carcinoma: The MSKCC experience (2005) (4)
Long-Term Survival in Oligometastatic Head and Neck Cancer (2017) (4)
Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer. (2017) (4)
A Single Institution's Experience With Maxillary Sinus Cancer (2013) (4)
Prospective Dysphagia Quality of Life Scores and Treatment Outcomes in Oropharyngeal Cancer Patients: Is it Time to Reconsider the Prophylactic Percutaneous Endoscopic Gastrostomy? (2013) (4)
1914MO Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912 (2020) (4)
Doxorubicin and concurrent radiotherapy for anaplastic thyroid cancer: We need to do better (2007) (4)
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation. (2020) (4)
Current considerations for radiotherapy in HPV‐associated head and neck cancer (2021) (4)
Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent? (2013) (4)
Radiation therapy and low dose doxorubicin in thyroid cancer: A phase II study. (2016) (3)
Proton Beam Re-Irradiation for Recurrent Head and Neck Cancer: Multi-Institutional Report on Feasibility and Early Outcomes (2016) (3)
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy (2022) (3)
HPV‐associated oropharyngeal cancer de‐escalation strategies and trials: Past failures and future promise (2021) (3)
Cancer of the Larynx (1971) (3)
A Multi-institution Pooled Analysis of G-Tube Dependence in Patients With Oropharyngeal Cancer Treated With Definitive IMRT (2013) (3)
Target volume delineation in intensity-modulated radiation therapy (IMRT) for head and neck cancer and correlation with patterns of failure (2002) (3)
Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation (2013) (3)
PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer (2019) (3)
Advances in the Technology of Radiation Therapy for Nasopharyngeal Carcinoma (2010) (3)
Intensity-modulated radiation therapy for head and neck cancer of unknown primary. (2006) (3)
Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab. (2019) (3)
SU-F-303-16: Multi-Atlas and Learning Based Segmentation of Head and Neck Normal Structures From Multi-Parametric MRI (2015) (3)
Phase II Randomized Trial Comparing Proton Craniospinal Irradiation with Photon Involved-Field Radiotherapy for Patients with Solid Tumor Leptomeningeal Metastasis (2022) (3)
Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: Secondary Analysis of Keynote 048. (2022) (3)
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9,468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial. (2021) (3)
Reproducibility of Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography (FMISO PET) in Detecting Chronic Hypoxia (CH) in Head/Neck Cancer (HNC) (2005) (3)
Noninvasive assessment of tumor microenvironment using dynamic contrast enhanced MRI and 18 F- fluoromisonidazole PET imaging in neck nodal metastases (2010) (3)
Forward-planned treatment techniques using multisegments for head and neck cancer (2002) (3)
Postoperative Radiation Therapy to Pathologically Negative Neck Nodal Stations in Patients With Indications for Radiation Therapy at the Primary Site. (2020) (3)
The Paranasal Sinuses (2013) (3)
Endoscopic Resection Followed by Proton Therapy With Pencil Beam Scanning for Skull Base Tumors (2018) (3)
Pathogenic Mutations in ATM As Determinants of Local Control in Non-Small Cell Lung Cancers Treated with Radiation Therapy (2018) (3)
Radiotherapy to demonstrate persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid cancer. (2018) (3)
Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience (2020) (3)
Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure (2021) (3)
In response to Drs. Yao, Dornfeld, and Buatti: the importance of target volume delineation (2004) (3)
A Personalized Approach Using Hypoxia Resolution to Guide Curative-Intent Radiation Therapy Dose-Reduction to 30 Gy: A Novel De-escalation Paradigm for HPV-Associated Oropharynx Cancers Treated With Concurrent Chemoradiation Therapy (2017) (3)
Squamous Cell Carcinoma of Unknown Primary in the Head and Neck (2013) (3)
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration (2021) (3)
Comparison of Different Methods of FDG-PET Target Volume Delineation in the Radiotherapy of Head and Neck Cancer (2007) (3)
The Immobilization Performance of a Novel “Open-Face” Mask Used for the Setup of Claustrophobic Patients Being Treated for Head-and-Neck Cancers (2012) (2)
Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck. (2016) (2)
Temporal Lobe Radiation Necrosis After Primary Radiation Involving the Skull Base With Proton Therapy: An Institutional Experience (2018) (2)
An Unusual Cause of Isolated Vomiting (2012) (2)
Comparison of cisplatin (CDDP) and radiation (RT) to cetuximab (C) and RT for locally advanced head and neck cancer (LAHNC): A preliminary analysis. (2009) (2)
Neck Dissection Without Postoperative Radiation Therapy in Select Patients With Oral Cavity Carcinoma and pN1 neck (2012) (2)
Sparing Bilateral Ib and Contralateral High Level II Nodes in Node-Positive (n+) Oropharyngeal Carcinoma (OPC) Improves Quality of Life on a Prospective Self-Reported Xerostomia Questionnaire (2013) (2)
A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer. (2012) (2)
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial. (2023) (2)
Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab. (2020) (2)
Radiation Therapy in the Treatment of Angiosarcoma of the Head and Neck (2010) (2)
Patterns of failure in head and neck cancer patients treated with intensity modulated radiation therapy: editorial response (2017) (2)
Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with 18f-fluoromisonidazole positron emission and computed tomography (18F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases. (2009) (2)
Impact of Surgery and External Beam Radiation Therapy on Local Control in the Treatment of Medullary Thyroid Carcinoma (2018) (2)
Correlation of 18F-Fluoromisonidazole Positron Emission and Computed Tomography (18F-FMISO PET/CT) with Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in Assessing Tumor Hypoxia in Head and Neck Cancer(HNC) Patients with Nodal Metastases (2009) (2)
Efficacy of concurrent cetuximab (C225) versus 5-fluorouracil/carboplatin (5FU/CBDCA) or cisplatin (CDDP) with intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNSCC). (2012) (2)
Weekly On-Treatment MRIs During Radiation Therapy (RT) in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients to Monitor Treatment Response (2014) (2)
Long-Term Update of a Phase II Study of Concurrent Chemoradiotherapy Using Radiation + Bevacizumab (BV) For Locally or Regionally Advanced Nasopharyngeal Cancer (NPC): RTOG 0615 (2020) (2)
HPV cell free DNA as a marker of response to chemoradiation for HPV-positive oropharngeal cancers. (2016) (2)
Optimal dose/volume constraints of sensitive structures in inverse planning for nasopharyngeal carcinoma (2001) (2)
Outcome of Endoscopic Management of Complete Cervical Esophageal Obstruction (2006) (2)
Multi-Institution Analysis of Intensity Modulated Radiation Therapy–Based Reirradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the Modern Era (2016) (2)
Sparing Low-Risk Nodes in Node-Positive (n+) Oropharyngeal Carcinoma (OPC) Improves Dysphagia Outcomes and Chronic PEG Rates (2013) (2)
Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC). (2013) (2)
Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma (2019) (2)
Optimal mass transport kinetic modeling for head and neck DCE‐MRI: Initial analysis (2019) (2)
WE-E-17A-03: FDG-PET-Based Radiomics to Predict Local Control and Survival Following Radiotherapy. (2014) (2)
Qualitative and Quantitative Performance of Magnetic Resonance Image Compilation (MAGiC) Method: An Exploratory Analysis for Head and Neck Imaging (2022) (2)
Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors (2021) (2)
Intensity Modulated Radiation Therapy (IMRT) for the Treatment of Oropharyngeal Carcinoma (OPC): Effect of Tumor Volume on Clinical Outcomes (2010) (2)
Hypoxia Imaging for Image-Guided Radiotherapy (2010) (2)
Osteoradionecrosis (ORN) of the Mandible in Head/Neck Cancer Treated with Intensity Modulated Radiation Therapy (IMRT) (2008) (2)
Oropharyngeal Cancer Patients and Mandibular Dose Distributions Following Intensity Modulated Radiation Therapy (2012) (2)
Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis (2022) (2)
Pathogenic Mutations in ATM Predict for Enhanced Local Control in Prostate Cancers Treated with Radiation Thearpy (2018) (2)
Dysphagia Quality of Life Scores and Treatment Outcomes in Oropharyngeal Cancer Patients: Is it Time to Reconsider the Prophylactic Percutaneous Endoscopic Gastrostomy?: Definitive Management of Head-and-Neck Squamous Cell Carcinoma (2014) (2)
Last-line Treatment with the Quad Shot Regimen for Previously Irradiated Head and Neck Cancers (2019) (2)
A Multi-institution Pooled Analysis of G-Tube Dependence in Patients With Oropharyngeal Cancer Treated With Definitive IMRT: Definitive Management of Head-and-Neck Squamous Cell Carcinoma (2014) (2)
The Increasing Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States (2016) (2)
Nasopharynx cancer: Induction or adjuvant? That is the question (2020) (2)
New Tracers PET in Head and Neck Squamous Cell Carcinoma. (2012) (2)
Neck Spasms as a Late Effect of Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancer (2011) (2)
Methods of reducing skin toxicity due to extended-field intensity-modulated radiation therapy (EF-IMRT) for the treatment of head and neck cancers (2001) (2)
Validating the AJCC 8th Edition of the Oral Cavity Cancer Staging System: A Multi-institutional Collaborative Study (2018) (2)
KEYNOTE-689: A Phase 3 Study of Neoadjuvant and Adjuvant Pembrolizumab Plus Standard of Care (SOC) in Resectable, Locally Advanced (LA) Head and Neck Squamous Cell Carcinoma (HNSCC) (2023) (2)
Proton Therapy for Non-Skull Base Head and Neck Adenoid Cystic Carcinoma (2020) (2)
Multiparametric imaging of tumor hypoxia and perfusion with 18 F-FMISO dynamic PET in head and neck cancer (2017) (2)
Pre- and Postinduction Chemotherapy Target Volume Delineation in Head and Neck Cancer: Preliminary Results from an Expert Panel (2009) (2)
Correlation of Planned Dose to Area Postrema and Dorsal Vagal Complex With Clinical Symptoms of Nausea and Vomiting in a Series of Oropharyngeal Cancer (OPC) Patients Treated With Radiation Alone Using IMRT (2012) (2)
Carcinoma of the paranasal sinuses (2014) (1)
Quantitative analysis of blood-borne 18F-FMISO metabolites in cancer patients by HPLC using an integrated high-sensitivity coincidence detector (2015) (1)
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma (2023) (1)
A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx. (2019) (1)
Plenary 5: Analyzing Serial Hypoxia Images From 18FMISO-PET: Modeling Transient and Chronic Hypoxia (2006) (1)
Proton Therapy for Nasopharyngeal Cancer: A Matched Case-control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy (2020) (1)
Dorsal vagal complex of the brainstem: Conformal avoidance to reduce nausea. In regard to Monroe et al. (2015) (1)
Carcinoma of the Nasopharynx (2017) (1)
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer. (2022) (1)
Trends and Patterns of Proton Therapy Utilization Among Patients With Head and Neck Cancer: Analysis from the National Cancer Database (2005-2014) (2018) (1)
Evaluating compliance with process‐related quality metrics and survival in oral cavity squamous cell carcinoma: Multi‐institutional oral cavity collaboration study (2020) (1)
Can Meaningful and Durable Locoregional Control Be Achieved for Oral Cavity Squamous Cell Carcinoma (OCSCC) Treated With Definitive Radiation Therapy (RT) (2012) (1)
The relationship between parotid gland-PTV overlap and the ability to achieve dosimetric sparing of the parotid using intensity modulated radiation therapy (2004) (1)
SU-E-T-583: Feasibility of Constraining Dose to the Nausea Center (area Postrema and Dorsal Vagal Complex) in IMRT Treatment Planning of the Head and Neck. (2012) (1)
Skull Base Surgery for Radiation-Associated Tumors in Retinoblastoma Patients (2009) (1)
Toward Improving Treatment Planning Quality and Efficiency Using Knowledge Engineering and Autoplanning: A Study Based on NRG-HN001 Clinical Trial (2016) (1)
Natural history following recurrence after definitive locoregional treatment in 1000+ cases of locally advanced head and neck squamous cell carcinoma. (2016) (1)
The Investigation of a Decision Support Metric for Head and Neck Adaptive Radiation Therapy using a Real-Time In Vivo Portal Dosimetry System (2018) (1)
Surgery Improves Outcome in Recurrent Squamous Cell Carcinoma of the Oral Cavity (2012) (1)
Pulmonary Complications of Radiation Therapy (2018) (1)
Comparison of Objective Measures of Trismus and Salivation With Patient-reported Outcomes Following Treatment for Head and Neck Cancer. (2022) (1)
External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors (2013) (1)
Oral Cavity Cancers (2013) (1)
Pathogenic Mutations in ATM Enhance Radio-Sensitivity and Local Control in Patients with Primary and Metastatic Breast Cancer (2018) (1)
Proton Quad Shot RT for Palliation in Patients With Advanced Sarcoma (2017) (1)
Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center (2021) (1)
Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies (2020) (1)
Correlation of the Dose Delivered to the Nausea Center With Acute Onset of Nausea and Vomiting in Oropharynx Cancer Patients Treated With Chemoradiation (2012) (1)
Reproducibility of radiomic features using network analysis and its application in Wasserstein k-means clustering (2021) (1)
Multi-Institution Analysis of Intensity Modulated Radiation Therapy–Based Reirradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival (2016) (1)
Advanced Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiation Therapy (2014) (1)
Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab (2019) (1)
Re-irradiation of Locally Recurrent Nasopharyngeal Cancer (2008) (1)
An imbalance in competing mortality favouring Debio 1143. (2020) (1)
Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center. (2019) (1)
Dosimetric Correlation of the Muscles of Mastication with Trismus in Patients Undergoing Intensity Modulated Radiotherapy (IMRT) and Chemotherapy for Oropharyngeal Carcinoma (OPC) (2010) (1)
Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma (2013) (1)
Patterns of Failure (POF) After Salvage Reirradiation (re-RT) for Recurrent Head-and-Neck Cancer (HNC): Implications for Field Design and Consolidation Therapy (2012) (1)
Tumors of the Nasopharynx (2018) (1)
Gastrostomy Tube Dependence in Patients With Oropharyngeal Cancer Treated by Definitive IMRT: A Modern Benchmark (2017) (1)
TU-E-141-05: Dosimetric and Anatomical Evaluation of Normal Tissue Changes During IMRT Radiotherapy for Head and Neck Cancer. (2013) (1)
Incidence and Distribution of Nodal Metastases in Sinonasal Malignancy (2018) (1)
Dose Response of Dysphagia in Head and Neck Cancer Patients (2011) (1)
Head and Neck Target Delineation among Radiation Oncology Residents after a Teaching Intervention: Feasibility and Preliminary Results (2008) (1)
2391: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Cancer of the Larynx/Hypopharynx (2006) (1)
The Role of Postoperative PET/CT Imaging in Head-and-Neck Cancer Patients Prior to the Initiation of Adjuvant Radiation Therapy (2012) (1)
Maxillary Dose Distributions Following Intensity-Modulated Radiation Therapy: A Pilot Study (2012) (1)
Outcomes of postoperative treatment with concurrent chemoradiotherapy (CRT) in high risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration. (2019) (1)
S 001 A PREDICTIVE MODEL FOR GASTROSTOMY TUBE PLACEMENT IN PATIENTS UNDERGOING SURGERY FOR UPPER AERODIGESTIVE TRACT LESIONS (2014) (1)
Outcomes in Recurrent Head and Neck Cancer after Salvage Surgery and Flap Reconstruction with Postoperative Reirradiation (re-RT) (2011) (1)
Abstract CT285: KEYNOTE-689: A phase 3 study of neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) (2020) (1)
Neck spasms: A late sequela of head and neck irradiation. (2016) (1)
Oropharyngeal Cancer Early Outcomes and Challenges During the COVID-19 Pandemic (2021) (1)
Recursive Partition Analysis Identifies Oropharyngeal Cancer Patients at High Risk for Distant Metastasis (2012) (1)
Preliminary Results of a Prospective Trial of IMRT Dose De-escalation to Gross Nodal Disease in Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma (OPC) Based on Assessment of Tumor Hypoxia Using 18F-FMISO PET Imaging (2014) (1)
Parotid gland fat related Magnetic Resonance Image biomarkers improve prediction of late xerostomia (2018) (1)
Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC). (2021) (1)
Prospective Personalized Elective Nodal Dose De-Escalation in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Definitive Concurrent Chemoradiation (CCRT): Acute Toxicities and Tolerance (2018) (1)
27 – Cancer of the Nasopharynx (2010) (1)
IMRT Versus Conventional Radiation Therapy for Postoperative Treatment of Oral Cavity Squamous Cell Carcinoma (OCSCC) (2012) (1)
Is IMRT Associated With Inferior Outcomes for T1-2N0 Squamous Cell Carcinoma of the Larynx? (2012) (1)
Identifying Biological Subtypes of Head and Neck Squamous Cell Carcinoma (HNSCC) From Contrast Enhanced CT Scans Using Radiomic and the Cancer Genome Atlas (TCGA) (2018) (1)
Excellent Laryngeal Preservation Can Be Achieved With IMRT for Locoregionally Advanced Laryngeal Cancer (2012) (1)
Final Analysis of Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression Trial - A Randomized Study of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Lung and Breast Cancers (2022) (1)
Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV Positive Oropharyngeal Cancer (OPC) (2020) (1)
Oral Scientific SessionsCombined FDG and CT Radiomics Features Predict FMISO Uptake in Head and Neck Cancer (2017) (1)
Comparison of Electron versus IMRT Treatment Planning for Extensive Squamous Cell Carcinoma (SCC) of the Scalp (2011) (1)
Atypical metastasis of nasopharyngeal cancer: noncontiguous spread to the ipsilateral ear. (2020) (1)
Metastasis Directed Therapy with Definitive Intent is Associated with Improved Survival in Metastatic Head and Neck Cancer (2018) (1)
Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice Patterns (2017) (1)
Palliative Head and Neck Radiation Therapy With the Quad Shot Regimen for Incurable Primary or Metastatic Cancers (2014) (1)
Application of Community Detection Algorithm to Investigate the Correlation between Imaging Biomarkers of Tumor Metabolism, Hypoxia, Cellularity, and Perfusion for Precision Radiotherapy in Head and Neck Squamous Cell Carcinomas (2021) (1)
WE-AB-207B-08: Exploring and Refining the QUANTEC Guideline to Reduce Severe Hyposalivation Following IMRT for Head and Neck Cancer. (2016) (1)
Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC). (2017) (1)
Palliative Radiation Therapy by the RTOG 85-02 Regimen for Incurable Primary or Metastatic Head and Neck Cancers (2015) (1)
Outcomes for Locally Advanced Laryngeal Cancer Treated With Definitive Chemoradiation With Intensity Modulated Radiation Therapy (2016) (1)
Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT). (2015) (1)
Comparison of outcomes following recurrence or metastasis in HPV+ and HPV- oropharyngeal carcinoma treated with definitive chemoradiation using IMRT. (2016) (1)
Kurtosis analysis for DWI improves prediction of short-term response in head and neck cancer (2010) (1)
Effects of Liver Metastases and Liver-Metastasis-Directed Radiotherapy on Response to Immunotherapy. (2021) (1)
Long-Term Outcomes of Definitive Radiation Therapy for Nasopharyngeal Carcinoma at a North American Institution: Definitive Management of Head-and-Neck Squamous Cell Carcinoma (2014) (1)
Optimal Mass Transport Kinetic Modeling for Head and Neck DCE-MRI: Initial Analysis (2019) (1)
Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer (2020) (1)
Low-lying Cervical Metastases Predict for Distant Metastasis in N2 Oropharyngeal Cancer Patients Treated with Intensity Modulated Radiotherapy (2011) (1)
Impact of cetuximab on chemoradiation use in older patients with locally advanced head and neck cancer. (2013) (1)
Update of Radiation Techniques Using Photons for Anterior Skull Base Tumors. (2020) (1)
Outcomes of Radiation Therapy for Hypopharyngeal Squamous Cell Carcinoma: A Single Institution Experience (2012) (1)
Long-term Regional Control in the Observed Neck following Definitive Chemoradiation for Node-positive Oropharyngeal Squamous Cell Cancer (2011) (1)
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study. (2022) (1)
Prognostic Variables of Adenoid Cystic Carcinoma of the Head and Neck: A Recent Experience (2007) (1)
IMRT for Carcinomas of the Nasopharynx (2006) (1)
American Head and Neck Society position statement on the use of PD‐1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma (2022) (1)
Chapter 34 – Nasopharyngeal Carcinoma (2016) (1)
Feasibility of Using 3D Uniform Conformal Scanning Proton Beam Therapy for Locally-Advanced Oropharyngeal Carcinoma Requiring Bilateral Neck Irradiation (2013) (0)
Reirradiation Outcomes After Upfront Larynx Preservation or Total Laryngectomy: A Multi-institutional Analysis (2016) (0)
Target Delineation of the Neck in Head and Neck Carcinomas (2014) (0)
Introduction: Head and neck cancer. (2012) (0)
Post-Operative Radiotherapy in the Treatment of Paranasal Sinus and Nasal Cavity and Cancer (2005) (0)
Outcomes of post-operative treatment with concurrent systemic therapy and radiotherapy (RT) in intermediate (INT) risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration. (2019) (0)
SP-0398: An image-based approach to investigate sensitive tissues related to trismus following head and neck radiotherapy (2013) (0)
1H-MRS and 18FDG PET: Metabolism in head and neck cancers (2009) (0)
DCE-MRI as a predictor of outcome in head and neck squamous cell carcinoma patients with nodal metastases (2009) (0)
2374 : Intensity-Modulated Radiation Therapy (IMRT) Versus Conventional Radiotherapy Using Delayed Accelerated Concomitant Boost (CBRT) for Patients With Locally Advanced Oropharyngeal Carcinoma (2006) (0)
Fatigue Associated with Radiotherapy: Short and Long-term Fatigue Level Trajectories in Patients with Oropharyngeal Cancer (2011) (0)
S020 Significance of Viable Tumor in Postchemoradiation Neck Dissections (2006) (0)
The Influence of Smoking and Age on Pathologic Features and Outcomes in Oral Cavity Squamous Cell Cancer: A Multi-institutional Collaborative Study (2018) (0)
In response to Drs. Clark et al. (2003) (0)
The Impact of Histopathologically Measured Gross Tumor Volume on Outcome in Patients Treated Surgically for Oropharyngeal Squamous Cell Carcinoma (2012) (0)
Real-World Evaluation of Consolidative Durvalumab in Locally Advanced Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation (2019) (0)
SU-E-J-137: Incorporating Tumor Regression Into Robust Plan Optimization for Head and Neck Radiotherapy. (2014) (0)
Long-term Outcomes of Postoperative Radiation Therapy for Major Salivary Gland Tumors (2012) (0)
Melanoma metastatic to multiple visceral organs: further considerations. (2010) (0)
Toxicity and efficacy of concomitant chemoradiotherapy (CCRT) in elderly patients with oropharyngeal carcinoma (OPC) in the intensity modulated radiotherapy (IMRT) era. (2016) (0)
Evaluation of the AJCC 7 th , ICON-S, and HPV-Path Staging Systems for Surgically Managed HPV/p16+ve Oropharyngeal Squamous Cell Carcinoma Patients (2018) (0)
Long-Term Update of Proton Beam Re-Irradiation for Recurrent Head and Neck Cancer (2020) (0)
Cancer of the Head and Neck (2020) (0)
2 Rationale , Instrumental Accuracy , and Challenges of PET Quantification for Tumor Segmentation in Radiation Treatment Planning (2017) (0)
Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Technical Factors (2016) (0)
Treatment of Base of Tongue (BOT) Cancer: Conventional External Beam Radiotherapy (EBRT) Alone vs. EBRT + Brachytherapy vs. Intensity Modulated Radiotherapy (IMRT) (2010) (0)
Chemoradiation Is a Safe and Effective Treatment in Patients With Gross Residual or Unresectable Non-Anaplastic Thyroid Cancer (2014) (0)
To Shy Away From Chemotherapy Is to Compromise. (2020) (0)
Outcomes and Late Effects: A Comparison of Patients with Locally-advanced Head and Neck Cancer (LAHNC) Treated with Cisplatin (CDDP) and Radiation (RT) vs. Cetuximab (C) and RT (2009) (0)
WE-AB-202-11: Radiobiological Modeling of Tumor Response During Radiotherapy Based On Pre-Treatment Dynamic PET Imaging Data. (2016) (0)
ASO Visual Abstract: Well Differentiated Thyroid Cancer-Who Should get Postoperative Radiation? (2022) (0)
Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer (2021) (0)
A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC) (2019) (0)
PO-1550: Radiomics characteristics correlate with immune activation and HPV status in head and neck cancer (2020) (0)
Subjective Hearing Loss (SHL) after Chemoradiation for Nasopharyngeal and Oropharyngeal Cancer Patients (2011) (0)
Radiation Therapy in the Treatment of Cutaneous Angiosarcoma of the Head and Neck (2013) (0)
Patterns of Regional Nodal Failure Following Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma (2016) (0)
Avelumab in Combination with Standard of Care Chemoradiotherapy Versus Chemoradiotherapy Alone in Patients with Locally Advanced Scchn: A Randomised, Double-Blind, Phase 3 Trial (2020) (0)
Neoadjuvant and adjuvant pembrolizumab (pembro) plus standard of care (SOC) in patients (pts) with resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): The phase III KEYNOTE-689 study (2019) (0)
Endoscopic Resection Followed by Proton Beam Therapy With Pencil Beam Scanning: A Multidisciplinary Approach to Tumors of the Skull Base (2018) (0)
Chapter 32 – Nasopharyngeal Carcinoma (2012) (0)
Sparing Bilateral IB in Node-Positive Oropharyngeal Carcinoma Improves Xerostomia Outcomes (2014) (0)
External Beam Radiation Therapy in Advanced or Recurrent Nonanaplastic Thyroid Cancer: An Updated Experience (2012) (0)
Enhancing Enrollment of Patients to Radiation Oncology Clinical Trials Across a Multi-Institutional Community-Academic Partnership: An Interrupted Time Series Analysis. (2021) (0)
Radiation Treatment Breaks: Are They Detrimental to Outcomes for Oropharyngeal Carcinoma Treated with Definitive Chemoradiation? (2020) (0)
Multivariable Analysis of Factors Associated With Outcome in Localized Sinonasal Mucosal Melanoma (SM) (2012) (0)
Radiotherapy of NPC Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy (2014) (0)
Localized Sinonasal Mucosal Melanoma: Outcomes and Associations With Stage, Radiation Therapy, and Positron Emission Tomography Response (2016) (0)
Evaluating the Role of PET/CT Imaging in the Postoperative Setting of Oral Cavity Squamous Cell Cancers Prior to Adjuvant Radiation Therapy (2013) (0)
Role of External Radiation Therapy in Patients With Advanced or Recurrent Non-Anaplastic Thyroid Cancer: The Memorial Sloan-Kettering Cancer Center Experience (2007) (0)
PARP imaging with 18F-PARPi in patients with head and neck cancer (2020) (0)
Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy (2022) (0)
Surgery Followed by Postoperative Radiation Therapy for Minor Salivary Gland Tumors (2012) (0)
Ethmoid Sinus Cancer: Experience and Oncological Outcomes at Memorial Sloan-Kettering Cancer Center (MSKCC) (2014) (0)
Improving Prognostic Classification in Intermediate Risk (INT) Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-institutional Collaborative Study (2018) (0)
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps (2021) (0)
Comparative Analysis of Mandibular Dosimetric-Distribution of PBRT/IMRT: A Pilot Study (2016) (0)
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H- MRS, DCE MRI and 18F-FDG PET: an exploratory study (2010) (0)
Patterns of local extension and nodal involvement from 1300 nasopharyngeal carcinoma patients: An imaging-based predictor of distant metastases. (2019) (0)
A narrative review of intensity-modulated proton therapy for head and neck cancer (2022) (0)
Head and Neck Cancers Associated With Exposure to the September 11, 2001, World Trade Center Terrorist Attacks (2018) (0)
External Beam Radiation With or Without Concurrent Chemotherapy in Non-anaplastic Thyroid Cancer With Unresectable or Gross Residual Disease (2017) (0)
Recurrent/Metastatic Head and Neck Cancer: When and How to Irradiate (2017) (0)
Salivary Gland Tumors (2018) (0)
Kinetic analysis of 18F-FMISO dynamic PET using shortened datasets (2015) (0)
A Multi-Institutional Comparison of Carboplatin-Based Regimens Versus Cetuximab in Chemoradiation for p16(-) Head and Neck Cancer (2018) (0)
Comparison of 18FDG and 18FMISO uptakes and distributions in head and neck cancer tumors (2014) (0)
Oral Cavity Cancer (2014) (0)
Preliminary results of concurrent chemotherapy with intensity-modulated radiation therapy (IMRT) for advanced cancer of the larynx/hypopharynx. (2006) (0)
Clinical Investigation : Head and Neck Cancer A Phase 1 Study of Everolimus D Weekly Cisplatin D Intensity Modulated Radiation Therapy in Head-and-Neck Cancer (0)
SU‐FF‐J‐38: Evaluation of Positioning for Head and Neck Patients Using 2D and 3D Image Guidance (2009) (0)
Chest wall irradiation with intensity- and energy-modulated electron beams (2003) (0)
WE‐D‐AUD C‐02: Hypoxia‐guided Intensity‐Modulated Radiation Therapy for Head and Neck Cancer (2008) (0)
An Estimation of the Radiation Therapy Dose–Response Differences Between FDG-Avid Versus FDG-Nonavid Head-and-Neck Tumors (2013) (0)
Radical Reduction of Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus (HPV) - Associated Oropharyngeal Carcinoma (OPC) (2020) (0)
Regaud, Rare Skin Cancer, and Radiotherapy. (2022) (0)
Low-dose Radiation to the Nerve Alone Impairs Perineural Invasion Independent of Cancer Cell Death (2012) (0)
Role of Postoperative Radiotherapy in Management of Well Differentiated Thyroid Carcinoma with Gross Extrathyroidal Extension: Memorial Sloan-Kettering Cancer Center Experience (2011) (0)
Predicting Outcomes after Salvage Reirradiation of Recurrent Head and Neck Cancer (2010) (0)
Particle Beam Radiation Therapy for Nasopharyngeal Cancer (2021) (0)
Ultra-high-dose Stereotactic Body Radiation Therapy (SBRT) is Feasible for Tumors in the Head and Neck (HN) (2012) (0)
Proton Beam Radiation Therapy (PBRT) Results in Significantly Reduced Acute Toxicity Rates Compared With Intensity Modulated Radiation Therapy (IMRT) When Treating the Ipsilateral Neck for Head and Neck Cancer (2014) (0)
Methodologic Concerns in Secondary Analysis of KEYNOTE-048-Reply. (2022) (0)
Outcomes of p16-Positive EBV-Negative Nasopharyngeal Carcinoma Treated with Definitive Chemoradiation at a Large North American Cancer Center (2017) (0)
Second Malignancies After Salivary Gland Cancer: A Population-Based Analysis (2007) (0)
Establishing an Offline Evaluation Process for IMRT/VMAT Radiation Therapy Treatment Planning Quality Using Knowledge-Based Planning: A Study Based on Multi-institutional Head and Neck Clinical Trial (2017) (0)
Outcomes of Patients with Synchronous Head and Neck and Lung Cancers who were Treated for Cure with Multi-modality Approach (2019) (0)
Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review. J Radiat Oncol 1:129-146 (2012) (0)
Genomic Analysis of Exceptional Responders to Low-Dose Radiation Therapy Reveals Somatic Mutations in ATM. (2016) (0)
PD-0299 CORRELATIONS OF SPATIAL DOSE DISTRIBUTION WITH TRISMUS IN A COHORT OF HEAD AND NECK RADIOTHERAPY PATIENTS (2012) (0)
Weekly On-Treatment MRIs During Radiation Therapy (RT) in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients to Monitor Normal Tissue Response (2014) (0)
Salvage Therapy for Locoregionally Recurrent Head and Neck Cancer Occurring in a Previously Irradiated Field: A National Survey of Practice Patterns (2016) (0)
Pre-/Posttreatment Dosimetric Parameters in Osteoradionecrosis Patients Following Intensity-Modulated Radiation Therapy (2012) (0)
Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Patient Selection and Pre- and Post-Stereotactic Body Radiation Therapy Evaluation (2016) (0)
Outcomes of Proton and Carbon Ion Radiation Therapy for Head and Neck Sarcomas (2018) (0)
Primary chondrosarcomas of the larynx treated with proton radiotherapy: A single institutional experience (2022) (0)
Impact of Postoperative Chemoradiation for HPV Positive Oropharyngeal Cancers with Extranodal Extension and/or Positive Margins (2018) (0)
Proton radiotherapy for incurable recurrent or metastatic cancers of the head and neck by the RTOG 8502 hypofractionated palliative schedule. (2016) (0)
Temporal Lobe Radiation Necrosis after Proton Re-irradiation Therapy Involving the Skull Base (2018) (0)
High Dose Rate Intraoperative Radiotherapy for Recurrent Head and Neck Cancer (2007) (0)
SP-0395: Accidents and near misses in radiotherapy delivery, and the ACCIRAD project (2010) (0)
Adjuvant Radiation in the TORS Era – Is There a Benefit to Omitting the Primary Site? (2016) (0)
Changing the Paradigm in HPV-Negative Oropharyngeal Cancer: Deintensification Based on Low Risk of Locoregional Relapse (2020) (0)
Incidence and Prognostic Significance of Perineural Invasion in Patients with Paranasal Sinuses and Skull Base Cancer (2007) (0)
SU-E-J-83: Evaluation of Landmark-Assisted Deformable Image Registration Technique On Inter-and Intra-Patient Head and Neck CT Imaging. (2013) (0)
Outcomes In Early-stage Sinonasal Melanoma: The MSKCC Experience (2011) (0)
Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation? (2022) (0)
SU‐C‐BRB‐02: Exploring the Correlation Between 3D Spatial Dose Distribution and Toxicity in Normal Tissue (2012) (0)
P064) Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in the Elderly (2017) (0)
Proton Radiotherapy for Recurrent or Metastatic Sarcoma with Palliative Quad Shot and SBRT (2019) (0)
Upregulation of Alternative End Joining in HPV+ Head and Neck Cancer (2017) (0)
Predictive Factors for Locoregional Control After Salvage Reirradiation of Recurrent Head-and-Neck Cancer (2012) (0)
What to Expect When You're Expecting: Managing Oral Cavity Cancer in the Setting of a Second Trimester Pregnancy. (2022) (0)
Intra-Treatment Tumor Apparent Diffusion Coefficient, a Quantitative Imaging Metric, is Associated with Neck Nodal Recurrence in De-Escalated Treatment of HPV-Positive Oropharyngeal Cancer (OPC) (2022) (0)
PO-0890: PET-based radiobiological modeling of changes in tumor hypoxia during chemoradiotherapy (2017) (0)
Superficial Radiotherapy For Cutaneous Melanoma (2009) (0)
Patterns of Care and Radiation Therapy Utilization Among Patients With Soft Tissue Sarcoma of the Head and Neck: A National Cancer Database Analysis (2018) (0)
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma. (2021) (0)
Treatment of maxillary sinus cancer in the modern era: one institution’s experience (2014) (0)
The Relationship of Numerical Chromosomal Instability With Clinical Characteristics and Outcomes in Head and Neck Cancers Treated With Multimodality Therapy (2016) (0)
Concurrent Intensity Modulated Radiation Therapy (IMRT) With Cisplatin (CDDP) versus 5-Fluorouracil/Carboplatin (5FU/P) For Head and Neck Cancer (HNC) (2011) (0)
Patient selection for immunotherapy in head and neck cancer - Authors' reply. (2021) (0)
Definitive Photon Radiation Therapy in the Treatment of Unresectable Salivary Gland Tumors (2012) (0)
Outcomes in a Select Group of Patients With Medullary Thyroid Carcinoma (MTC) Treated With Radiation Therapy (2011) (0)
Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer (2022) (0)
Dosimetric Evaluation of Trismus in Head and Neck Cancer Patients following Intensity Modulated Radiation Therapy and Chemotherapy (2011) (0)
CLO20-041: Prognostic Factors in Major Salivary Gland Tumors Treated with Adjuvant Radiation Therapy (2020) (0)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) (0)
Does Integration of Advanced Practice Provider in Radiation Oncology Influence UCC Visit Rate of Head and Neck Cancer Patients Treated with Definitive Radiation Therapy? (2020) (0)
Patterns of Nodal Failure After Intensity Modulated Radiation Therapy for Patients With Nasopharyngeal Carcinoma (2016) (0)
Head and Neck PATTERNS OF FAILURE AFTER COMBINED-MODALITYAPPROACHES INCORPORATING RADIOTHERAPY FOR SINONASAL UNDIFFERENTIATED CARCINOMA OF THE HEAD AND NECK (2010) (0)
Locoregional Patterns of Failure in Oropharyngeal Carcinoma: Implications for Treatment De-escalation (2012) (0)
Is Smoking Related to a More Aggressive Oral Cavity Squamous Cell Carcinoma with Poor Survival? A Multi-Institutional Collaborative Study (2019) (0)
Mandibular Dose Distribution Following Intensity-Modulated Radiation Therapy (2012) (0)
Dynamic Contrast Enhanced ( DCE )-MRI and 18 Fluoromisonidazole ( 18 F MISO ) PET Imaging in head and neck squamous cell carcinoma : Initial evaluation of perfusion and hypoxia in nodal metastasis (2007) (0)
In Reply to Drs. Mehrotra and Mishra (2010) (0)
76 Factors associated with post-obstruction uropathy after treatment with permanent prostate seed implantation (2000) (0)
Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer (2022) (0)
A Unique Complication Associated with Concurrent Chemoradiation for the Treatment of Locally Advanced Head and Neck Cancer (2008) (0)
Long-Term Outcomes of Definitive Radiation Therapy for Nasopharyngeal Carcinoma at a North American Institution (2013) (0)
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis (2022) (0)
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. (2023) (0)
The Prognostic Value of Hypoxia-Reoxygenation During Chemoradiation Therapy in Locoregionally Advanced Head-and-Neck Cancer (2012) (0)
Outcomes Following Radiation Therapy for Anaplastic Thyroid Cancer (2018) (0)
HPV-Positive Oropharyngeal Cancers: Midtreatment PET During Radiation Therapy and Implications for Treatment De-escalation (2014) (0)
1 H-MRS and 18 FDG PET : Metabolism in head and neck cancers (2008) (0)
Reproducibility of SUVmax in serial PET studies (2009) (0)
Radiation Therapy Demonstrates Persistent Overall Survival Benefit in Locally Advanced or Metastatic Anaplastic Thyroid Cancer (2018) (0)
High-Dose Chemoradiation Irrespective of Age. (2021) (0)
2771: Cone Beam CT Monitoring of IMRT Head and Neck Treatment (2006) (0)
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiation Therapy (2014) (0)
Split High-Dose Cisplatin: An Alternate High-Dose Cisplatin Administration Schedule for Definitive Chemoradiation in Oropharyngeal Cancer (2020) (0)
The Role of Radiation Therapy in Perineural Invasion: A Translational Approach (2011) (0)
A Novel Modeling for Salivary Toxicity Based on Salivary Flow Recovery Over Time in Head-and-Neck Cancer Patients Treated With Radiation Therapy (2012) (0)
Improved Outcomes by proton beam radiation for nasal cavity and paranasal sinus malignances (2020) (0)
Regional Recurrence Risk With Level V Omission in Locally Advanced Oropharyngeal Squamous Cell Carcinoma (2015) (0)
RE-IRRADIATION FOR RECURRENT HEAD AND NECK CANCER: IN REGARD TO LEE ET AL. (INT J RADIA T ONCOL BIOL PHYS 2007;68 :731-740). Author's reply (2007) (0)
Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) as a Predictor of Response in Head and Neck Squamous Cell Carcinoma (HNSCC): Initial Analysis (2007) (0)
Laryngeal Preservation Strategy for Locally Advanced Laryngeal Cancer in the Era of IMRT (2014) (0)
Natural History Following Recurrence After Definitive Locoregional Treatment in 1000+ Cases of Locally Advanced Head and Neck Squamous Cell Carcinoma (2016) (0)
Dose Response of Dysphagia in Oropharynx Cancer Patients (2010) (0)
A Multicenter Experience in Contralateral Submandibular Gland Sparing in Head and Neck Radiation Therapy: An Assessment of Feasibility and Safety (2014) (0)
Efficacy and Safety of Three or More Courses of Radiation for Head and Neck Malignancies (2018) (0)
Comparison of Outcomes Following Recurrence or Metastasis in HPV+ and HPV- Oropharyngeal Carcinoma Treated With Definitive Chemoradiation Using IMRT (2016) (0)
The Use of Transit Fluence as a Decision Support Metric for Head and Neck Adaptive Radiation Therapy (2019) (0)
Treatment Outcomes for Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer (2022) (0)
Loco-Regional Relapse and Predictors of Outcome in Early Stage Oral Cavity Cancers (pT1-2N0) Treated with Surgical Monotherapy with or without Neck Dissection: A Multi-Institutional Study (2018) (0)
Tumor diffusion and metabolism in head and neck cancer : pretreatment multimodality imaging with DW-MRI and 18 F-FDG PET (2010) (0)
68 – Cancer of the Head and Neck (2014) (0)
Prognosis of P16 and HPV Discordant Oropharyngeal Cancers: Natural Language Processing to Extract Data from Free-Text Pathology Reports (2022) (0)
Management of locally and regionally advanced nasopharyngeal carcinoma with chemoradiotherapy (2014) (0)
Proton Therapy and Incidence and Predisposing Factors of Osteoradionecrosis-On Pulling One's Punches-Reply. (2023) (0)
Long-term Therapeutic and Functional Outcomes With Organ Preservation for T4 Larynx and Hypopharynx Cancers. (2021) (0)
Metabolic Tumor Volume Is Superior to Gross Tumor Volume in Predicting Outcomes in Patients With Oropharyngeal Cancer Treated With IMRT (2012) (0)
SU-E-J-238: Monitoring Lymph Node Volumes During Radiotherapy Using Semi-Automatic Segmentation of MRI Images. (2014) (0)
Correlation of Intravoxel Incoherent Motion with Dynamic Contrast Enhanced MRI Derived Parameters in Neck Nodal Metastases (2010) (0)
Dosimetric Comparison of Intensity Modulated Radiotherapy (IMRT) and Intensity Modulated Proton Therapy (IMPT) for Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue (2022) (0)
In Reply to Dr. Nieder (2007) (0)
30 – Cancer of the Hypopharynx (2010) (0)
Can the Risk of Dysphagia in Head and Neck Radiation Therapy Be Predicted by an Automated Transit Fluence Monitoring Process During Treatment? A First Comparative Study of Patient Reported Quality of Life and the Fluence-Based Decision Support Metric (2021) (0)
Number of Lymph Nodes Examined Is Associated With Overall Survival in Clinically Node-Negative Oral Cavity Cancer Patients Receiving Definitive Surgery—A Population-Based Analysis Using the National Cancer Data Base (2016) (0)
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) as a predictor of response in head and neck squamous cell carcinoma (HNSCC) (2007) (0)
Feasibility of incorporating patient reported outcomes (PROs) into routine care for oropharyngeal carcinoma (OPC). (2017) (0)
Influence of Treatment Package Time on Outcomes in High-Risk Oral Cavity Carcinoma in Patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Collaborative Study (2019) (0)
Phase 2 Trial of Intensity-Modulated Radiation Therapy +/- Concurrent Doxorubicin for Patients With Locally Advanced or Recurrent Non-anaplastic Thyroid Cancer (2017) (0)
Head and Neck DEVELOPMENT AND VALIDATION OF A STANDARDIZED METHOD FOR CONTOURING THE BRACHIAL PLEXUS : PRELIMINARY DOSIMETRIC ANALYSIS AMONG PATIENTS TREATED WITH IMRT FOR HEAD-AND-NECK CANCER (0)
SU-E-T-460: Comparison of Proton and IMRT Planning for Head and Neck Cancer. (2014) (0)
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer (2018) (0)
Predictors of Immunotherapy Response in Head and Neck Cancer: Per Lesion Analysis of a Prospective Randomized Trial with Nivolumab (2020) (0)
A population-based three dimensional atlas of the head and neck lymph nodes for conformal (IMRT) radiotherapy (2002) (0)
Basal cell and squamous cell skin cancers. (2010) (0)
Tolerance and Efficacy of Extracranial Radiation Therapy During Ipilimumab Immunotherapy for Metastatic Melanoma (2012) (0)
Long Term Outcomes and Prognostic Factors of Head and Neck Soft Tissue Sarcoma (HNSTS) Treated with Definitive Therapy (2018) (0)
Late-Breaking Abstracts: ASTRO's 64th Annual Meeting (October 23-26, 2022) Study of vs. Followed by (2022) (0)
Automated tracking of morphologic changes in weekly magnetic resonance imaging during head and neck radiotherapy. (2023) (0)
Development of Models to Predict Radiation Dosimetric Distribution in Different Regions of the Jaw in Patients Receiving Radiation Therapy to the Head and Neck (2017) (0)
Assessment of tumor microenvironment using DCE MRI and 18Fluoromisonidazole PET imaging in neck nodal metastases (2009) (0)
Development and Validation of Diagnostic Interpretation Criteria for Evaluation of F-18 Fluoromisonidazole Hypoxia PET/CT – Inter-Reader Reliability and Accuracy (2022) (0)
Omission of Elective Retropharyngeal Nodal Irradiation Superior to Vertebral Level C1 is Not Associated With Retropharyngeal Nodal Failure in N0-N2b Oropharyngeal Cancer Patients Treated With Definitive Chemoradiation (2015) (0)
29 – Cancer of the Oral Cavity (2010) (0)
GDC-0032, A Novel p110α Inhibitor, Specifically Radiosensitizes Head and Neck Squamous Cell Carcinomas Harboring Activating PIK3CA Alterations (2014) (0)
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Survival and Response to Therapy in Patients Treated with Immune Checkpoint Inhibitors (2020) (0)
Outcomes after Salvage Therapy in Oral Cavity Squamous Cell Carcinoma (OCSCC) Patients Who Developed Locoregional Failure (LRF) after Definitive Surgery and Adjuvant (chemo)Radiotherapy: A Multi-Institutional Collaborative Study (2018) (0)
SU-F-J-104: Weekly MRI for Dose Assessment of Organs at Risk During Treatment of HN Cancer of the Oropharynx. (2016) (0)
Irradiation for Regionally Only Recurrent, Never-Irradiated Oral Cavity Cancers (2016) (0)
WE‐C‐303A‐03: Pharmacokinetic Analysis of Hypoxia 18‐Fluoromisonidazole Dynamic PET Imaging in Head and Neck Cancer (2009) (0)
Reproducibility test of radiomics using network analysis and Wasserstein K-means algorithm (2019) (0)
Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers (2021) (0)
Can Metabolic Tumor Volume Further Risk Stratify Patients Eligible for Treatment Deintensification in the Newly Proposed HPV-Associated Oropharyngeal Cancer Staging System? (2015) (0)
Elective versus Therapeutic Neck Dissection in Oral Cancer. (2015) (0)
Salvage Radiotherapy Leads to Worse Overall Survival Compared to Adjuvant Radiotherapy in Oral Cavity Carcinoma: A Matched Analysis (2017) (0)
Development of a standard set of dose constraints to sensitive structures in treatment of nasopharyngeal cancers using inverse planned IMRT (2002) (0)
Major Salivary Glands (2013) (0)
Early Stage Larynx Cancer (2014) (0)
WE-FG-202-07: An MRI-Based Approach to Quantify Radiation-Induced Normal Tissue Injury Applied to Trismus After Head and Neck Cancer Radiotherapy. (2016) (0)
A Pilot Study Of Using Pre- And Early (1 Week) [18f]-misonidazole Positron Emission And Computed Tomography (18F-FMISO PET/CT) Scans As An Early Treatment Response Predictor In A Series Of Head and Neck Cancer (HNC) Patients Undergoing Chemoradiation (2011) (0)
Triggered GTV-Based Offline Adaptation for LINAC Head and Neck Radiotherapy (2022) (0)
Mid-Treatment PET During Radiation Therapy in HPV-Positive Oropharyngeal Cancer Patients Demonstrates Variable Response: Implications for Treatment De-escalation (2014) (0)
Dose and Volume De-Escalation for Elective Nodal Regions in Patients With Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Curative-Intent Concurrent Chemoradiation (CCRT). (2021) (0)
Physician Graded Toxicity Profiles and Survival Outcomes among Patients with Non-Metastatic Oropharyngeal Carcinoma Treated with Proton Therapy vs. Intensity-Modulated Radiation Therapy (2022) (0)
Temporal Lobe Radiation Necrosis after Primary Radiation involving the Skull Base with Proton Therapy (2018) (0)
Tumor Volume Predicts for Baseline Hypoxia Status in HPV Related Oropharyngeal Carcinomas (OPC) that Underwent Major Radiation De-escalation: The 30 Reduction in Oropharyngeal Cancer Trial (2022) (0)
Oral Cavity Tumors (2018) (0)
In Reply to Theriat et al. (2012) (0)
Knowledge-Based Models for NRG HN001 Proton Plan Quality Analysis. (2021) (0)
Preliminary clinical studies with the tumor hypoxia PET tracer 124I-IAZGP (2007) (0)
Comparison of Patient Reported Xerostomia Risk and the Fluence-based Decision Support Metric (2020) (0)
Rebuttal to Drs. Hu and Harrison (2005) (0)
Knowledge-Based Model for the Evaluation of NRG-HN001 Radiotherapy Treatment Plan Quality (2019) (0)
Mean Dose to Larynx as a Predictor of Late Dysphagia after Definitive Intensity Modulated Radiotherapy (IMRT) for Squamous Cell Carcinoma (SCC) of the Head and Neck (2011) (0)
A Nomogram to Predict Severe Late Toxicity after Definitive Reirradiation for Squamous Carcinoma of the Head and Neck (2017) (0)
Bolus Versus Weekly Chemotherapy in Definitive Chemoradiation for Nasopharyngeal Cancer (2018) (0)
Post-operative Radiotherapy after Complete Surgical Resection for Head and Neck Mucosal Melanoma (2008) (0)
TERT Promoter Mutations Among Oral Cavity Cancers: A Pattern of Failure Analysis (2019) (0)
The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers (2021) (0)
Outcomes of Major Salivary Gland Tumors Treated with Proton Beam Radiation Therapy (2020) (0)
Primary Tumor Metabolic Volume Improves Risk Prediction of Long-term Outcomes in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy (2011) (0)
Does every patient with newly diagnosed prostate cancer need an abdominal and pelvic computed tomography scan as well as a radionuclide bone scan (1998) (0)
Deep Learning Autosegmentation Model for NRG-HN001 Contour Quality Assurance (2019) (0)

This paper list is powered by the following services: